- THIS ARTICLE
-
Abstract
- Full Text (PDF)
- Alert me when this article is cited
- Alert me if a correction is posted
- SERVICES
- Similar articles in this journal
- Similar articles in PubMed
- Alert me to new issues of the journal
- Download to citation manager
- Reprints & Permissions
- CITING ARTICLES
- Citing Articles via HighWire
- Citing Articles via Google Scholar
- GOOGLE SCHOLAR
- Articles by Koning, A. J.
- Articles by Wright, R. L.
- Search for Related Content
- PUBMED
- PubMed Citation
- Articles by Koning, A. J.
- Articles by Wright, R. L.
Mutations That Affect Vacuole Biogenesis Inhibit Proliferation of the Endoplasmic Reticulum in Saccharomyces cerevisiae
Ann J. Koning1,a, Lynnelle L. Larson2,a, Emily J. Caderaa, Mark L. Parrish3,a, and Robin L. Wrightaa Department of Zoology, University of Washington, Seattle, Washington 98195-1800
Corresponding author: Robin L. Wright, University of Washington, Box 351800, Seattle, WA 98195-1800., wrightr{at}u.washington.edu (E-mail)
Communicating editor: E. W. JONES
| ABSTRACT |
|---|
In yeast, increased levels of the sterol biosynthetic enzyme, 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase isozyme, Hmg1p, induce assembly of nuclear-associated ER membranes called karmellae. To identify additional genes involved in karmellae assembly, we screened temperature-sensitive mutants for karmellae assembly defects. Two independently isolated, temperature-sensitive strains that were also defective for karmellae biogenesis carried mutations in VPS16, a gene involved in vacuolar protein sorting. Karmellae biogenesis was defective in all 13 other vacuole biogenesis mutants tested, although the severity of the karmellae assembly defect varied depending on the particular mutation. The hypersensitivity of 14 vacuole biogenesis mutants to tunicamycin was well correlated with pronounced defects in karmellae assembly, suggesting that the karmellae assembly defect reflected alteration of ER structure or function. Consistent with this hypothesis, seven of eight mutations causing defects in secretion also affected karmellae assembly. However, the vacuole biogenesis mutants were able to proliferate their ER in response to Hmg2p, indicating that the mutants did not have a global defect in the process of ER biogenesis.
CELLS modulate many of their structural features in response to changes in physiology or environment. Control of membrane structure and function appears to be particularly responsive to changing metabolic conditions. For example, the area of endoplasmic reticulum (ER) increases threefold as naïve B cells differentiate into immunoglobulin secreting cells (![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
![]()
In response to Hmg1p, one of the two yeast HMG-CoA reductase isozymes, yeast assemble a nuclear-associated array of stacked ER membranes called karmellae (![]()
![]()
![]()
![]()
![]()
![]()
To investigate the molecular events required for HMG-CoA reductase-induced membrane biogenesis, we carried out a genetic screen to identify trans-acting factors that affect karmellae biogenesis. We hypothesized that at least some of the genes involved in karmellae biogenesis would also play essential roles in regulating membrane homeostasis. Consequently, we screened several thousand temperature-sensitive mutants for their ability to assemble karmellae at permissive and nonpermissive temperatures. Mutants that were defective for karmellae biogenesis, yet still expressed high levels of Hmg1p, were retained for further analysis. Two independently isolated strains carried mutations in the same complementation group, which we discovered to be VPS16, a gene initially identified because of its role in vacuole biogenesis (![]()
| MATERIALS AND METHODS |
|---|
Yeast strains and media:
The strains used in this study are shown in Table 1 and the plasmids are shown in Table 2. Most yeast strains are derived from the S288C strain, JRY527. However, we were unable to delete PEP5 or VPS29 in this strain and obtained pep5
and vps29
deletion strains from the Saccharomyces Genome Deletion Project (via Research Genetics, Huntsville, AL). These deletion strains are also in an S288C background, either BY4739 or BY4741 (![]()
|
|
Yeast were grown either in minimal medium with appropriate amino acid and nucleotide base supplements (YM; ![]()
![]()
![]()
Deletion of vacuole biogenesis genes in JRY527 was accomplished using appropriate PCR products that carried portions of the 5' and 3' regions of the gene to be deleted and the geneticin-resistance marker, KanMX6 (![]()
![]()
![]()
![]()
![]()
![]()
mutation simultaneously removed a portion of the 3' end of open reading frame (ORF) YLR361C. In addition, the pep7
also removes the promoter of the TIM1 gene, probably placing it under control of the PEP7 promoter. Disruption was confirmed via PCR, using primers that hybridized to sequences flanking the deleted gene and within the KanMX6 sequence.
Plasmids:
The galactose-inducible HMG1 plasmid, pAK266, has been previously described (![]()
![]()
![]()
To clone the wild-type gene, vps16-101 mutant cells containing pAK444 were transformed with a genomic library (Sau3A partial digest) in pRS316 (![]()
![]()
![]()
Mutagenesis and isolation of mutants:
Independent cultures of RWY410 (JRY527 containing pAK266, a galactose-inducible HMG1 gene on a centromere-containing plasmid) were mutagenized with UV light to
50% survival and grown in the dark for 34 days at room temperature (22°24°). Colonies were replica plated to YM glucose medium and grown at 37° to identify temperature-sensitive colonies. Temperature-sensitive strains were recovered from the original plate, streaked onto solid medium to produce single colonies, and then patched onto YM glucose medium. The patches were replica plated to YM galactose + raffinose medium to induce karmellae assembly and incubated overnight at 37° or for 2 days at room temperature. For analysis of karmellae assembly, cells were picked from these plates into multiwell slides containing 2.5 µl of DiOC6 solution (1 ml of yeast culture medium + 3 µl of a 10-mg/ml stock solution of DiOC6 in ethanol) and screened for karmellae membranes using fluorescence microscopy. Prospective mutants were streaked on 5-fluoroorotic acid plates (![]()
Isolation of genomic DNA and PCR:
Genomic DNA was isolated from overnight cultures (510 ml) using glass bead lysis and phenol extraction as described in ![]()
![]()
Immunoblot analysis:
Eight OD600 units of cells were centrifuged at 800 x g for 3 min and the cell pellet was frozen at -80°. The frozen cell pellet was disrupted by glass bead lysis as previously described (![]()
![]()
![]()
![]()
Microscopy:
For electron microscopy, cells were grown as described above, fixed with 2% glutaraldehyde followed by 2% potassium permanganate, and embedded in Spurr's resin as previously described (![]()
![]()
![]()
Allele rescue and sequencing:
The vps16-101 and vps16-102 alleles were rescued from the yeast genome by plasmid gap repair (![]()
300-bp intervals. Sequencing reactions were analyzed on an ABI377 automated DNA sequencer (Applied Biosystems, Foster City, CA). The 5' and 3' flanking ends of pAK473 and pAK477 (a plasmid from an independent transformant that also complemented vps16-101) were sequenced using the Taq dye primer cycle sequencing kit (Applied Biosystems).
| RESULTS |
|---|
A fluorescence-microscopy screen of temperature-sensitive mutants identified karmellae biogenesis mutants:
Yeast cells with increased levels of Hmg1p assemble karmellae membranes, yet have no other readily discernible phenotype. In addition, karmellae are asymmetrically segregated at mitosis, such that the mother cell retains karmellae membranes and the daughter cell inherits an unelaborated ER structure (![]()
![]()
![]()
Of
2500 temperature-sensitive strains screened, 215 initially showed some alteration in karmellae biogenesis. When cured of the plasmid and then retransformed with the original plasmid containing the galactose-inducible HMG1, 20% of the mutants no longer displayed an alteration in karmellae biogenesis, indicating that the karmellae phenotype resulted from mutations in the original plasmid. These strains were not investigated further. Since the generation of karmellae membranes requires increased levels of Hmg1p, any chromosomal mutation that affected expression from the GAL1 promoter would be scored as defective in karmellae biogenesis. Almost one-half (45%) of the originally identified mutations were presumed to be gal-, since they were able to generate karmellae membranes when HMG1 was expressed from the CUP1 promoter. Of the 22 potential karmellae assembly mutants, 11 assembled less than one-half of expected karmellae levels when HMG1 was expressed from either the GAL1 or the CUP1 promoter and were retained as karmellae-defective mutants. All 11 mutations were karmellae defective at both permissive and nonpermissive temperatures, were recessive, and, except for D1Z and D20i, were in different complementation groups.
Because they were in the same complementation group, we initially focused on mutants D1Z and D20i. As in the other mutants examined, the temperature sensitivity and karmellae biogenesis defects in DiZ and D20i mutants cosegregated (data not shown). In wild-type yeast cells containing the copper-inducible HMG1 gene (pAK220), 35% of the cells contained karmellae membranes after 5 hr of copper induction at permissive temperature (24°). At 37°, 62% of wild-type cells contained karmellae membranes. In contrast, karmellae were present in 7% of D1Z cells at permissive temperature and in 2% of the population at restrictive temperature. D20i cells displayed similar defects in karmellae assembly. Mutants D1Z and D20i also had densely stained cytoplasm at both permissive and restrictive temperature and lacked any obvious vacuole (Fig 1B, Fig C, Fig E, and Fig F).
|
Hmg1p levels remained elevated in D1Z and D20i mutants:
The level of Hmg1p in D1Z and D20i strains was compared to that of wild-type cells (Fig 2). Both D1Z and D20i mutants had elevated levels of Hmg1p, yet the percentage of cells with karmellae membranes in the mutant populations was much lower than expected given the level of Hmg1p in the cell. This defect in karmellae assembly was more pronounced in cultures grown at 37°, the nonpermissive temperature for the mutant strains.
|
The D1Z and D20i mutations were complemented by plasmids containing VPS16:
To clone the wild-type copy of the gene defective in D1Z and D20i, strain D1Z containing a copper-inducible HMG1 gene in a 2µ HIS3 vector (pAK444) was transformed with a centromeric URA3 genomic library and grown at restrictive temperature. Plasmids that complemented both the temperature-sensitive growth and karmellae biogenesis defects were isolated from two independent transformants. The sequence at the ends of the insert in these plasmids revealed that they both contained DNA from the same region of chromosome XVI. Fragments of the 13-kb insert in one of the complementing plasmids, pAK472, were subcloned to identify the smallest complementing region. One subclone containing only the VPS16 gene complemented both the temperature-sensitive growth and karmellae biogenesis defects of both D1Z and D20i. Consequently, it appeared that D1Z and D20i had lesions in the VPS16 gene and we have named these new alleles of VPS16 as follows: D1Z, vps16-101; and D20i, vps16-102.
The vps16-101 and vps16-102 mutations encoded truncated versions of Vps16p:
The karmellae biogenesis-defective alleles vps16-101 and vps16-102 were recovered from the genome by plasmid gap repair and sequenced. In vps16-101, a transversion at nucleotide 1778 from a T to A produced a premature stop codon, resulting in truncation of the protein at amino acid 592 compared to the full-length protein of 798 amino acids. In vps16-102, a deletion of nucleotides 1715 and 1716 produced a frameshift, resulting in translation of 11 altered amino acids before reaching a premature stop codon that truncated the protein at amino acid 582. Therefore, both alleles of vps16 with defects in karmellae biogenesis encoded similarly truncated proteins lacking the last one-quarter of Vps16p.
The vps16-101 and vps16-102 mutants have abnormal vacuole and karmellae ultrastructure:
VPS16 had been previously identified because of its role in the assembly and function of the vacuole (![]()
![]()
![]()
|
Vacuole dynamics were abnormal in vps16-101 and vps16-102:
Dynamics of endocytic delivery of membrane to the vacuole can be characterized by staining with the styryl dye, N-(3-triethylammoniumpropyl)-4-(r-diethylaminophenylhexatrienyl) pyridinium dibromide (FM4-64; ![]()
![]()
![]()
![]()
cells (Fig 5B and Fig E; see also ![]()
![]()
pep3 cells). Interestingly, labeling of the nuclear envelope was observed in the mutants, suggesting that the endocytic pathway may be altered in vps16 mutants.
|
|
Hmg1p displayed a normal ER localization pattern in vps16 mutants:
To determine whether vps16-101 and vps16-102 mutants might be unable to assemble karmellae because they did not properly target Hmg1p to the nuclear envelope/ER, the localization of Hmg1p was examined by indirect immunofluorescence. The Hmg1p in both mutants was present in the nuclear envelope and peripheral ER in a similar pattern as in wild-type cells (Fig 5). One noticeable difference was the more diffuse staining pattern of Hmg1p at 37° in the vps16 strain. This difference may reflect the altered morphology of proliferated ER membranes in some cells as seen by electron microscopy (Fig 3).
We also examined the localization of an Hmg1:GFP fusion protein in living wild-type and vps16
cells. This analysis required that the cells be cultured at 30° rather than at 37°, since the wild-type GFP protein used in this analysis fluoresces poorly at higher temperatures (![]()
mutants completed approximately one doubling while wild-type doubled approximately four times. In both the mutant and wild type, Hmg1:GFP was localized largely in the nuclear envelope, frequently in an asymmetric pattern with increased staining on one side (Fig 5E and Fig F). Unlike the immunofluorescence patterns, staining of peripheral ER elements was not frequently observed (an example is shown in Fig 5E). The different staining pattern probably reflects the lower expression produced from the GAL1 promoter vs. the CUP1 promoter. Similar to the immunofluorescence analysis, the localization of Hmg1:GFP in vps16
was similar to that of wild-type cells. Based on these observations, it appeared unlikely that the inability of vps16 mutants to assemble karmellae was due to abnormalities in Hmg1p localization. In addition, these results demonstrate that Hmg1p can become asymmetrically localized in the nuclear envelope without triggering karmellae assembly.
Overexpression of truncated Vps16-102p did not interfere with karmellae assembly in wild-type cells:
Vps16p is a rare protein that is present in a high-molecular-weight complex (![]()
![]()
![]()
![]()
|
The observation that both vps16-101 and vps16-102 encoded similarly truncated proteins suggested that these particular alleles might have novel effects. Consequently, we compared the phenotype of vps16-101 and vps16-102 point mutants to vps16
null mutants in which the entire coding sequence was replaced with HIS3 or with KanMX6. The vps16
strains had similar phenotypes as the point mutants, except that karmellae assembly defects appeared temperature sensitive in the deletion mutant rather than constitutive as in strains with the point mutations. Following induction of Hmg1p expression at permissive temperature, a vps16
population assembled karmellae in 25% of the cells whereas a vps16-101 or vps16-102 population assembled karmellae in 5% of the cells. Our original tetrad analysis had suggested that genes capable of modifying karmellae assembly at permissive temperature might be segregating in our crosses of the vps16 point mutants to wild type. Consequently, for analysis of karmellae assembly in other vacuole biogenesis mutants (see below), vps16
strains were used as negative controls.
Karmellae assembly was defective in other vacuole biogenesis mutants:
VPS16 is a member of the class C vacuole biogenesis genes; mutations in these genes result in severely fragmented vacuoles that are not acidified (![]()
![]()
, pep5
, and vps33
mutants to properly assemble karmellae membranes in response to increased levels of Hmg1p. The pep3
, pep5
, and vps33
strains had phenotypes similar to the
vps16 strain and were defective for karmellae biogenesis at 37° (Table 4). However, the karmellae assembly defect was less pronounced in the pep5
strain, which was able to assemble karmellae at
20% of expected levels at nonpermissive temperature (in contrast to the other class C mutants that assembled only 47% of expected levels). It is possible that this result reflected differences in strain background, since we were unable to generate pep5 or vps29 deletions in our strain background and obtained these strains from the Saccharomyces Genome Deletion Project (via Research Genetics).
|
The inability of all class C deletion mutants to assemble karmellae efficiently at nonpermissive temperature suggested that normal vacuole structure might be important for karmellae assembly at high temperatures. To test this hypothesis, deletion mutants in other vacuole biogenesis genes were evaluated for their ability to assemble karmellae at permissive and nonpermissive temperatures. Class A mutants have vacuoles that are morphologically similar to those of wild-type cells and are acidified (![]()
![]()
, vps29
, and vps38
) assembled lower levels of karmellae than wild type, but significantly higher levels than the class C mutants (Table 4). These results supported the hypothesis that abnormal vacuole structure might be an important factor in the severe karmellae assembly defects of class C mutants.
To test this hypothesis further, we took advantage of the intermediate vacuolar phenotype of class B mutants, which have highly fragmented, but acidified vacuoles (![]()
![]()
, was as karmellae defective as class C mutants, assembling only 13% of expected levels of karmellae at 37°. In contrast, another class B mutant, vps41
, was as karmellae proficient as class A mutants. Although the VAM3 gene has not been placed into the existing classification of vacuole biogenesis mutants, the defects of vam3
are consistent with it being another class B gene, since vam3 mutants have fragmented, acidified vacuoles (![]()
![]()
![]()
mutants was temperature sensitive to a similar level as the class C mutant, pep5
. Thus, the karmellae-assembly defects in class C mutants were not due to their profound abnormalities in vacuole structure, since intermediate alterations of vacuole structure did not uniformly display intermediate karmellae assembly defects.
We also examined the effects of class D and E mutations on karmellae assembly (Table 4). Class D mutants have a single large vacuole and are defective for vacuolar inheritance and acidification (![]()
![]()
![]()
![]()
, vps34
, and vps45
, as well as the single class E mutant tested, vps24
, were defective in karmellae assembly at nonpermissive temperature. Consequently, the severe karmellae assembly defects in a subset of vacuole biogenesis mutants were not caused by abnormal vacuole structure or abnormal acidification.
Expression from the CUP1 promoter occurs even in the absence of additional copper. Consequently, in our wild-type strain, sufficient Hmg1p is produced in the absence of copper to induce karmellae in 18% of the population grown at 26°. Thus, we can also examine whether vacuole biogenesis mutants were unable to assemble new karmellae or also had defects in retention of preexisting karmellae. Strains that were apparently unable to maintain the preexisting karmellae (i.e., displayed karmellae in significantly <18% of the population at nonpermissive temperature) include vps5
, pep3
, vps16
, vps33
, vps34
, and vps45
. In contrast, pep5
, pep7
, vps24
, and vam3
mutants were able to retain the karmellae that had been assembled at the time of copper addition and shift to nonpermissive temperature. Only vps8
, vps29
, vps38
, and vps41
mutants were able to assemble additional karmellae following the shift to high temperature.
The inability to assemble karmellae was not an immediate consequence of defects in ER-to-vacuole traffic, but displayed phenotypic lag:
To test whether the karmellae assembly defects were direct consequences of a block in delivery of proteins to the vacuole, we examined mutants containing an allele of PEP3 that is temperature sensitive for function (![]()
cells assembled karmellae after a shift to nonpermissive temperature. Thus, the inability to assemble karmellae was not an immediate result of blocking protein delivery to the vacuole. This result was not surprising, since the effects of pep3TSF on vacuole morphology and function also display phenotypic lag, such that normal morphology is observed for at least 5 hr following shift to nonpermissive temperature (![]()
Vacuole biogenesis mutations may affect ER function:
The inability of vacuole mutants to assemble karmellae might simply reflect morbidity of these strains at elevated temperatures. Consequently, it was important to determine whether temperature-sensitive growth was tightly correlated with defective karmellae assembly. Serial dilutions of deletion mutants, without plasmids, were plated onto YPD medium and growth was examined after incubation for 3 days at 26° or at 37° (Fig 6, top row).
|
Most karmellae assembly-defective strains (vps16
, pep3
, vps33
, pep7
, vps34
, and vps45
) were temperature sensitive for growth. However, other karmellae assembly-defective strains grew well at 37° (vps5
) or displayed limited growth (vps24
, vam3
, and pep5
). Consequently, temperature sensitivity was not a prerequisite condition for the presence of severe karmellae assembly defects at elevated temperature. This result makes it unlikely that the karmellae assembly defects were due simply to cell morbidity at elevated temperature.
An alternative hypothesis is that vacuole biogenesis mutations with severe karmellae assembly defects might have alterations in ER structure or function that affect karmellae assembly at elevated temperatures. If so, these mutants might be hypersensitive to drugs that target ER functions. To test this hypothesis, we grew the vacuole biogenesis mutants on YPD medium in the presence of the protein glycosylation inhibitor, tunicamycin (Fig 6, bottom right). Tunicamycin inhibits the activity of the ER protein, Alg7p, which catalyzes the first step in formation of dolichol-linked oligosaccharides needed for N-linked protein glycosylation (![]()
![]()
![]()
![]()
![]()
![]()
![]()
, the karmellae assembly-defective mutants were hypersensitive to tunicamycin (Fig 6 and Fig 7). Thus, tunicamycin hypersensitivity appeared to be a useful predictor of whether a vacuole biogenesis mutant was karmellae-assembly defective. This predictive value did not extend beyond vacuole biogenesis mutants, since both ire1
and hac1
mutants, which are tunicamycin sensitive and unable to activate the UPR, are able to assemble wild-type levels of karmellae (![]()
|
Many mutations that affect vacuole form and function result in a variety of drug sensitivities. Thus, rather than reflecting altered ER function, the hypersensitivity to tunicamycin might simply indicate general sensitivity of those strains to drugs or other insults. To test this hypothesis, we examined the growth of deletion mutants in the presence of a variety of drugs, both with ER and with other cellular targets (Fig 6). Clearly, the hypothesis that karmellae-defective mutants are uniformly sensitive to drugs is not supported. For example, vam3
and pep5
were actually more resistant to miconazole than the wild-type control were.
Assembly of ER in response to Hmg2p was largely unaffected by the vacuole biogenesis mutations:
Increased expression of Hmg2p induces proliferation of stacked ER membranes that, although similar to karmellae, have distinct morphology (![]()
|
Assembly of karmellae was also affected by secretory mutations:
On the basis of the data thus far, we considered it likely that inefficient clearing of vacuole proteins from the ER in the vacuole biogenesis mutants might produce altered protein composition within the ER, rendering it incompatible for karmellae assembly. This hypothesis predicts that blocking the ER-to-plasma membrane branch of the secretory pathway might also produce changes in ER composition that inhibit karmellae assembly. To test this hypothesis, we examined karmellae assembly at permissive and nonpermissive temperatures in eight temperature-sensitive secretory mutants (![]()
![]()
Seven of the eight secretory mutants we examined were severely defective in karmellae assembly at nonpermissive temperature, including sec63, sec12, sec17, sec18, sec7, sec1, and sec6 (Fig 7). At permissive temperature, all mutants except sec63 and sec12 were capable of karmellae assembly. Thus, the majority of secretory mutants displayed temperature-sensitive defects in karmellae assembly similar to those of vacuole biogenesis mutants. In contrast, sec63 and sec12 mutants were constitutively defective in karmellae assembly and sec14 mutants were able to assemble karmellae at both permissive and nonpermissive temperatures. On the basis of plating assays, the sec14 strain appears to be as temperature sensitive for growth as the other secretory mutants that we examined (our unpublished results). Consequently, the temperature-sensitive growth of the secretory mutants did not account for the karmellae assembly defects, as was observed for the vacuole biogenesis mutants.
| DISCUSSION |
|---|
In yeast, proteins that leave the Golgi apparatus have two major fates: Vacuolar proteins are delivered to the vacuole and secreted or plasma membrane proteins are delivered to the plasma membrane. With few exceptions, mutations that affect either of these branches of the secretory pathway also compromise karmellae assembly at high temperature. Since many of these mutants are also temperature sensitive for growth, the inability to assemble karmellae may simply be another characteristic of an already "sick" cell. Several observations weaken this possibility. First, if the inability to assemble karmellae simply reflects cell morbidity, karmellae assembly mutants should have been commonly encountered in our screen of random temperature-sensitive strains. Instead, karmellae assembly mutants were quite rare, comprising <1% of the several thousand temperature-sensitive strains screened. In addition, the "sick cell" hypothesis predicts that cells unable to assemble karmellae might be sick for a variety of reasons. Instead, nearly all of the karmellae assembly mutants that we obtained secreted carboxypeptidase Y (our unpublished results), a hallmark of defects in vacuole assembly. Thus, our screen for temperature-sensitive (TS) mutants with karmellae assembly defects appeared to efficiently identify vacuole biogenesis mutants. (Although secretory mutants should have been present in our original screen, they were undoubtedly discarded because their ER structure is not observable by DiOC6 staining after 12 hr of growth at nonpermissive temperature as used in our screen. Under these conditions, secretory mutants have a uniform, intensely bright staining pattern that is indistinguishable from that of cells that have simply died.)
Another observation that is inconsistent with the sick cell hypothesis is that the inability to assemble karmellae was not invariably correlated with temperature-sensitive growth. For example, sec14 is temperature sensitive, yet assembles normal levels of karmellae at high temperatures. In addition, vps5 is not temperature sensitive, yet assembles low levels of karmellae at high temperatures. Finally, all of the vacuole biogenesis mutants examined were reasonably proficient in assembling ER proliferations in response to Hmg2p, a protein with considerable sequence homology and identical catalytic activity to Hmg1p (![]()
![]()
Mutations with less effect on karmellae assembly (see Fig 8) were generally in genes with roles in retrograde traffic from the prevacuolar compartment to the Golgi or in anterograde traffic to the vacuole via the alternate pathway that bypasses the prevacuolar compartment (![]()
![]()
![]()
![]()
![]()
|
Many possible explanations might account for the karmellae assembly defects in most secretory and vacuole biogenesis mutants. For example, vacuoles may perform an essential function at elevated temperature that is also needed for karmellae assembly. However, our working hypothesis proposes that inefficient flux through the secretory and vacuole biogenesis pathways leads to altered ER composition and/or function. At lower temperatures, rates of insertion and removal of proteins and/or lipids remain sufficiently balanced to enable ER function to continue. However, at elevated temperatures, the increased rate of protein translocation into an ER with a compromised efflux may produce a molecular context in which karmellae assembly cannot occur and, perhaps, cause lethality in certain of the vacuole biogenesis mutants. The sensitivity of many of the vacuole biogenesis mutants to ER stresses such as tunicamycin and dithiothreitol (DTT), which inhibit protein processing in the ER, and resistance to miconazole, which inhibits an ER-localized step in ergosterol synthesis, is consistent with this prediction. Although this drug-sensitivity profile suggests that these mutants may be unable to activate the unfolded protein response (see ![]()
and hac1
mutants that cannot activate the UPR, nor does karmellae assembly itself activate the UPR (![]()
Although we have not resolved the mechanisms by which altered vacuole biogenesis and secretory functions inhibit karmellae assembly, the fact that merely expressing high levels of Hmg1p is not sufficient to induce karmellae assembly provides an important insight into the process of ER remodeling and biogenesis. For example, these results make it unlikely that karmellae assembly results directly from interactions between Hmg1p proteins themselves, as the "zippered membrane" hypothesis suggests (![]()
![]()
![]()
![]()
| FOOTNOTES |
|---|
1 Present address: Tilligen, 1000 Seneca St., Suite 200, Seattle, WA 98101. ![]()
2 Present address: Woodring College of Education, Western Washington University, Bellingham, WA 98225. ![]()
3 Present address: Rosetta Inpharmatics, 12040-115th Ave., NE, Kirkland, WA 98034. ![]()
| ACKNOWLEDGMENTS |
|---|
The authors thank Elizabeth Jones and anonymous reviewers for helpful comments on the manuscript. R.W. dedicates this manuscript to the indomitable spirit of the diverse, dedicated, and caring people of the United States of America. This work was supported by National Institutes of Health grant GM45726 and National Science Foundation grant 78287.
Manuscript received August 14, 2001; Accepted for publication January 14, 2002.
| LITERATURE CITED |
|---|
ANDERSON, R. G., L. ORCI, M. S. BROWN, L. M. GARCIA-SEGURA, and J. L. GOLDSTEIN, 1983 Ultrastructural analysis of crystalloid endoplasmic reticulum in UT-1 cells and its disappearance in response to cholesterol. J. Cell Sci. 63:1-20[Abstract].
BAGANZ, F., A. HAYES, D. MARREN, D. C. GARDNER, and S. G. OLIVER, 1997 Suitability of replacement markers for functional analysis studies in Saccharomyces cerevisiae. Yeast 13:1563-1573[Medline].







